BioCentury
ARTICLE | Financial News

Immunovaccine completes private placement

March 12, 2012 7:00 AM UTC

Immunovaccine Inc. (TSX-V:IMV), Halifax, Nova Scotia Business: Cancer, Infectious Date completed: 3/7/12 Type: Private placement Raised: C$2.8 million ($2.8 million) Shares: 9.3 million Price: C$0.30 ...